Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
The National Institutes of Health (NIH) on October 22, 2020 made updates to its COVID-19 Treatment Guidelines that provide information for clinicians in communities where influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are cocirculating.
Titled Influenza and COVID-19, the new section in the guideline discusses:
- Influenza vaccination for those with COVID-19
- Clinical presentation similarities/differences between the 2 viruses
- Potential for coinfection with influenza and SARS-CoV-2
- Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
- Treatment of influenza in the setting of cocirculatling SARS-CoV-2
Get a top-line review in the short slide show that follows.
Recent Videos
Related Content
